Tablo Announces $76.5M Investment.

*Bringing its total to $185.5M, Outset Medical announces a new investment from T. Row Price Associates. The Tablo machine is rethinking HD technology from the ground up. A minifridge-sized unit can purify tap water, send and receive data, and even clear air bubbles from the dialyzer and bloodlines.

Read the full article » | Posted 06-12-2017

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026